GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Life Stem Genetics LIFS · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 3 Nov 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2026

Net income

−$9,700

FY2024FY2026

Free cash flow

—

FY2024FY2026

Shareholders' equity

—

FY2024FY2026

Income statement

Fiscal years

FY2026FY2025FY2024
Operating income−$9,700−$10,540−$40,782
Net income−$9,700−$10,572−$40,782
Diluted earnings per share-0.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2026FY2025FY2024
Shares outstanding246m246m246m

Cash flow

Fiscal years

Latest quarters

By quarter end

Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024
Operating income−$300−$300−$300−$8,800−$950−$1,050−$2,300−$6,240
Net income−$300−$300−$300−$8,800−$950−$1,083−$2,300−$6,240
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-37.0%——
Net income-37.0%——

Valuation history

At each fiscal year end

FY2026FY2025FY2024
Price to earnings-2.5-1.6-0.2

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return100%-91%31885%0%0%100%0%300%13233%199900%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 13-for-1 split · 20 Sept 2013

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.